Literature DB >> 20329491

Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study.

Richard I Han1, Alexander Black, Geoffrey Culshaw, Anne T French, Brendan M Corcoran.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Myxomatous mitral valve disease (MMVD) is the single most common cardiac disease of the dog, and bears close similarities to chronic degenerative mitral valve disease in humans. However, limited quantitative data are available on cellular and morphological changes in both species. The study aim was to use an image analysis system to examine various morphological changes associated with MMVD, and in particular to measure changes in cell numbers in overtly myxomatous areas of the distal portion of the valve.
METHODS: Mitral valve complexes were collected from normal dogs and dogs with varying severity of myxomatous mitral valve disease (veterinary Whitney grades 1-4; a measure of disease severity and age-related disease progression in the dog). An image analysis technique (ImageJ; National Institutes of Health, USA) was used to measure valve leaflet length, thickness, connective tissue content and density, glycosaminoglycan (GAG) content, cell number and shape in normal and myxomatous areas of diseased valves.
RESULTS: There was a change in the valve leaflet anterior/posterior length ratio in the diseased valves, suggestive of valve lengthening. Distinct and statistically significant (p < 0.01) changes occurred in the valve thickness ratio for both anterior and posterior leaflets as the disease progressed, and the posterior leaflet thickness ratios were consistently higher than for the anterior leaflets. There was a statistically significant decrease in cell numbers in overtly myxomatous areas of the distal portion of affected valves compared to similar locations in normal valves, but there was no difference between the different grades of disease. The majority of cells in both diseased and normal valves had a circularity score typical of a spindle (elongated) shape. Connective tissue derangement was clearly seen in the myxomatous areas, and this was associated with a significant reduction in connective tissue density. The reduction in connective tissue density was associated with advancing disease severity (age). There was an increase in GAG expression with disease severity, as shown by the level of Alcian blue staining, but this could not be quantified with ImageJ.
CONCLUSION: Mitral valve myxomatous degeneration in the dog is associated with lengthening and thickening of valve leaflets, a loss of connective tissue, and a decrease in cell numbers in selected myxomatous areas, but no change in cell circularity. Some of these changes were age- (disease severity-) related.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20329491

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  7 in total

Review 1.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

Review 2.  The mechanobiology of mitral valve function, degeneration, and repair.

Authors:  Jennifer M Richards; Emily J Farrar; Bruce G Kornreich; N Sydney Moїse; Jonathan T Butcher
Journal:  J Vet Cardiol       Date:  2012-02-25       Impact factor: 1.701

3.  The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.

Authors:  Qiyu Tang; Andrew J McNair; Kanchan Phadwal; Vicky E Macrae; Brendan M Corcoran
Journal:  Front Cardiovasc Med       Date:  2022-05-17

Review 4.  New Imaging Technologies To Characterize Arrhythmic Substrate.

Authors:  Antonio Dello Russo; Sergio Conti; Ghaliah Al-Mohani; Michela Casella; Francesca Pizzamiglio; Corrado Carbucicchio; Stefania Riva; Gaetano Fassini; Massimo Moltrasio; Fabrizio Tundo; Martina Zucchetti; Benedetta Majocchi; Eleonora Russo; Vittoria Marino; Fabrizio Bologna; Luigi Di Biase; Andrea Natale; Claudio Tondo
Journal:  J Atr Fibrillation       Date:  2014-12-31

5.  Radiofrequency ablation alters the microstructural organization of healthy and enzymatically digested porcine mitral valves.

Authors:  J M Bender; W R Adams; A Mahadevan-Jansen; W D Merryman; M R Bersi
Journal:  Exp Mech       Date:  2020-10-26       Impact factor: 2.808

6.  ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.

Authors:  Bruce W Keene; Clarke E Atkins; John D Bonagura; Philip R Fox; Jens Häggström; Virginia Luis Fuentes; Mark A Oyama; John E Rush; Rebecca Stepien; Masami Uechi
Journal:  J Vet Intern Med       Date:  2019-04-11       Impact factor: 3.333

Review 7.  Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human.

Authors:  Greg R Markby; Kim M Summers; Vicky E MacRae; Brendan M Corcoran
Journal:  Vet Sci       Date:  2017-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.